Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Bladder cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬 💬
2 Bladder cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬 💬
3 Bladder cancer 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬 💬
4 Bladder cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 2件: 51, 86 💬 💬
5 Bladder cancer 💬
1件: EGFR 💬 Erlotinib 💬 Erlotinib 1件: 94 💬 💬
6 Bladder cancer 💬
1件: EGFR 💬 Gefitinib 💬 Gefitinib 1件: 75 💬 💬
7 Bladder cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬 💬
8 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬 💬
9 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬 💬
10 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬 💬
11 Bladder cancer 💬
1件: FGFR3 💬 Infigratinib 💬 Infigratinib 1件: 276 💬 💬
12 Bladder cancer 💬
1件: FGFR3 💬 Nintedanib 💬 Nintedanib 5件: 51, 85, 89, 227, 228 💬 💬
13 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬 💬
14 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib 1件: 280 💬 💬
15 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 1件: 34 💬 💬
16 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬 💬
17 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 4件:  2 , 34, 279, 280 💬 💬
18 Bladder cancer 💬
1件: SRC 💬 Bosutinib 💬 Bosutinib 2件:  2 , 67 💬 💬
19 Bladder cancer 💬
1件: SRC 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
20 Bladder cancer 💬
1件: SRC 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
21 Bladder cancer 💬
1件: SRC 💬 Saracatinib 💬 Saracatinib 3件:  6 , 89, 272 💬 💬
22 Bladder cancer 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬 💬
23 Bladder cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 6件: 13, 34, 85, 87, 227, 280 💬 💬
24 Bladder cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬 💬